Neutrophils and monocytes from subjects with the Mediterranean G6PD variant: Effect of Plasmodium falciparum hemozoin on G6PD activity, oxidative burst and cytokine production

European Cytokine Network

Volumn 9, Issue 3, 1998, Pages 239-245

  Mordmüller, Benjamin ^a,c   Turrini, Franco ^b   Long, Huayan ^a   Kremsner, Peter G ^a   Arese, Paolo ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TURIN   (Italy)

^c Institut fur Tropenmedizin   (Germany)

Author keywords

Hemozoin; IL 10; IL 12; Malaria; Oxidative burst; TNF

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOZOIN; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; PHORBOL ESTER; TUMOR NECROSIS FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; ERYTHROCYTE; GENE MUTATION; HUMAN; HUMAN CELL; LEUKOCYTE; MALARIA; MALE; MONOCYTE; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; RESPIRATORY BURST;

EID: 0031795459     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Vulliamy T, Mason P, Luzzatto L. 1992. The molecular basis of glucose 6-phosphate deficiency. Trends Genet. 8: 138.
2. Kletzien R F, Harris P K, Foellmi L A. 1994. Glucose 6-phosphate dehydrogenase: a "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. (Review) FASEB J. 8: 174.
3. Pandolfi P P, Sonati F, Rivi R, Mason P, Grosveld F, Luzzatto L. 1995. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate deydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 14: 5209.
4. Segal A W, Abo A. 1993. The biochemical basis of the NADPH oxidase of phagocytes. (Review) Trends Biochem. Sci. 18: 43.
5. Mac Micking J, Xie Q W, Nathan C. 1997. Nitric oxide and macrophage function. (Review) Annu. Rev. Immunol. 15: 323.
6. Maines M D. 1992. Heme oxygenase. Clinical applications and functions. Boca Raton: CRC Press, 63.
7. Gray G R, Stamatoyannopoulos G, Naimanm S C, Kliman M R, Klebanoff S J, Austin T, Yoshida A, Robinson G C F. 1973. Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. Lancet ii: 530.
8. Luzzatto L, Mehta A. 1995. Glucose 6-phosphate dehydrogenase deficiency. In: Scriver C R, Beaudet A L, Sly W S, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 3367.
9. Greene L S. 1993. G6PD deficiency as protection against falciparum malaria: an epidemiologic critique of population and experimental studies. Yr. Phys. Anthropol. 36: 153.
10. Martin S K. 1994. The malaria/G6PD hypothesis revisited. Parasitol. Today 10: 251.
11. Ramot B, Fisher S, Szeinberg A, Adam A, Sheba C, Gafni D. 1959. A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency. II. Investigation of leukocyte enzymes. J. Clin. Invest. 38: 2234.
12. Cooper M R, de Chatelet L R, McCall C E, LaVia M F, Spurr C L, Baehner R L. 1972. Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J. Clin. Invest. 51: 769.
13. Schwarzer E, Turrini F, Ulliers D, Giribaldi G, Ginsburg H, Arese P. 1992. Impairment of macrophage function after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J. Exp. Med. 176: 1033.
14. Schwarzer E, Arese P. 1996. Phagocytosis of malarial pigment hemozoin inhibits NADPH-oxidase activity in human monocyte-derived macrophages. Biochim. Biophys. Acta 1316: 169.
15. Metzger W G, Mordmüller B G, Kremsner P G. 1995. Malaria pigment in leucocytes. Trans. R. Soc. Trop. Med. Hyg. 89: 637.
16. Nguyen P H, Pram T D, Day N, Ferguson D J P, White N J. 1995. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans. R. Soc. Trop. Med. Hyg. 89: 200.
17. Beutler E. 1975. Red cell metabolism. A manual of biochemical methods. New York: Grune & Stratton, 62.
18. Schwarzer E, Turrini F, Arese P. 1994. A luminescence method for the quantitative determination of phagocytosis of erythrocytes, of malaria-parasitized erythrocytes and of malarial pigment. Br. J. Haematol. 88: 740.
19. Kremsner P G, Grundmann H, Neifer S, Sliwa K, Sahlmüller G, Hegenscheid B, Bienzle U. 1991. Pentoxifylline prevents murine cerebral malaria. J. Infect. Dis. 164: 605.
20. Clark I A, Hunt N H. 1983. Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect. Immun. 39: 1.
21. Rockett K A, Awburn M M, Cowden W B, Clark I A. 1991. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect. Immun. 59: 3280.
22. Prada J, Kremsner P G. 1995. Enhanced production of reactive nitrogen intermediates in human and murine malaria. Parasitol. Today 11: 409.
23. Bonsignore A, Fornaini G, Leoncini G, Fantoni A, Segni P. 1966. Characterization of leukocyte glucose 6-phosphate dehydrogenase in Sardinian mutants. J. Clin. Invest. 45: 1865.
24. Morellini M, Colonna-Romano S, Meloni T, Battistuzzi G, Gandini E. 1985. Glucose-6-phosphate dehydrogenase of leukocyte subpopulations in normal and deficient individuals. Haematologica 70: 390.
25. Rodey G E, Jacob H S, Holmes B, McArthur J R, Good R A. 1970. Leucocyte G.-6-P.D. levels and bactericidal activity. Lancet i: 355.
26. Morelli A, Benatti U, Gaetani G F, de Flora A. 1978. Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency. Proc. Natl. Acad. Sci. USA 75: 1979.
27. Piomelli S. 1987. G6PD deficiency and related disorders of the pentose pathway. In: Nathan D G, Oski F A, eds. Hematology of infancy and childhood. Philadelphia: W.B. Saunders, 583.
28. Luzzatto L, Meloni T. 1985. Hemolytic anemia due to glucose 6-phosphate dehydrogenase deficiency. In: Brain M C, Carbone P P, eds. Current therapy in hematology-oncology. Toronto: B.C. Decker Inc., 21.
29. Arese P, Schwarzer E. 1997. Malarial pigment (haemozoin): a very active "inert" substance. Ann. Trop. Med. Parasitol. 91: 501.
30. Pichyangkul S, Saengkrai P, Webster H K. 1994. Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-α and interleukin-1β. Am. J. Trop. Med. Hyg. 51: 430.
31. Prada J, Malinowski J, Müller S, Bienzle U, Kremsner P G. 1995. Hemozoin differentially modulates the production of interleukin-6 and tumor necrosis factor in murine malaria. Eur. Cytokine Netw. 6: 109.
32. Grau G E, Taylor T E, Molyneux M E, Wirima J J, Vasalli P, Hommel M, Lambert P H. 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320: 1586.
33. Kremsner P G, Winkler S, Brandts C, Wildling E, Jenne J, Graninger W, Prada J, Bienzle U, Juillard P, Grau G E. 1995. Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am. J. Trop. Med. Hyg. 53: 532.
34. Mordmüller B G, Metzger W G, Juillard P, Brinkman B M M, Verweij C L, Grau G E, Kremsner P G. 1997. Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur. Cytokine Netw. 8: 29.
35. Kremsner P G, Radloff P, Metzger W, Wildling E, Mordmüller B, Philipps J, Jenne L, Nkeyi M, Prada J, Bienzle U, Graninger W. 1995. Quinine plus clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother. 39: 1603.
36. De Waal Malefyt R, Abrams J, Bennet B, Figdor G G, de Vries J E. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209.
37. De Waal Malefyt R, Haanen J, Spits H, Roncarolo M G, de Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries J E. 1991. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II MHC expression. J. Exp. Med. 174: 915.
38. Ho M, Sexton M M, Tongtawe P, Looareesuwan S, Suntharasamai P, Webster H K. 1995. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J. Infect. Dis. 172: 838.
39. Anstey N M, Weinberg J B, Hassanali M Y, Mwaikambo E D, Manyenga D, Misukonis M A, Arnelle D R, Hollis D, McDonald M I, Granger D L. 1996. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med. 184: 557.
40. Peyron F, Burdin N, Ringwald P, Vuillez J P, Rousset F, Banchereau J. 1994. High levels of circulating IL-10 in human malaria. Clin. Exp. Immunol. 95: 300.
41. D'Andrea A, Aste-Amezaga M, Valiante N M, Ma X, Kubin M, Trinchieri G. 1993. Interleukin-10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178: 1041.
42. Meyaard L, Hovenkamp E, Otto S A, Miedema F. 1996. IL-12 induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J. Immunol. 156: 2776.
43. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547.
44. Fulton S A, Johnsen J M, Wolf S F, Sieburth D S, Boom W H. 1996. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect. Immun. 64, 2523.
45. Usanga E A, Luzzatto L. 1985. Adaptation of Plasmodium falciparum to glucose 6-phosphate dehydrogenase-deficient host red cells by production of parasite-encoded enzyme. Nature 313: 793.
46. Arese P, Cappadoro M, Giribaldi G, Turrini F. 1994. The malaria/G6PD hypothesis revisited: Reply. Parasitol. Today 10: 262.